Prion Diseases
Microglia in prion diseases
11
Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein
16
Amylotrophic Lateral Sclerosis Like Motor Impairment in Prion Diseases
15
Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases
5
Schwengler, Franziska (2005): Prion Diseases: A Genetic Perspective. Dissertation, LMU München: Tierärztliche Fakultät
177
Genomic and post-genomic analyses of human prion diseases
8
Progress and problems in the biology, diagnostics, and therapeutics of prion diseases
9
PrPScaccumulation in neuronal plasma membranes links Notch-1 activation to dendritic degeneration in prion diseases
13
Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases
17
Absence of CD14 Delays Progression of Prion Diseases Accompanied by Increased Microglial Activation
13
Molecular dynamic simulation studies of Q212H, V203G and N173K mutations in prion diseases
21
Orally Administered Amyloidophilic Compound Is Effective in Prolonging the Incubation Periods of Animals Cerebrally Infected with Prion Diseases in a Prion Strain-Dependent Manner
10
Low activity of complement in the cerebrospinal fluid of the patients with various prion diseases
7
Combined Diffusion Imaging and MR Spectroscopy in the Diagnosis of Human Prion Diseases
8
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases
18
Epidemiological characteristics of human prion diseases
10
Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases
12
An overview of animal prion diseases
8
An overview of human prion diseases
9
Molecular Pathogenesis of Prion Diseases
19